Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD [Corrigendum] od Buhl R, Banerji D

Preuzmi cijeli tekst

Future perspectives of anticholinergics for the treatment of asthma in adults and children od Buhl R, Hamelmann E

Preuzmi cijeli tekst

Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD od Buhl R, Banerji D

Preuzmi cijeli tekst

New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology od D'Urzo AD, Cazzola M, Hanania NA, Buhl R, Maleki-Yazdi MR

Preuzmi cijeli tekst

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study od Sauer R, Hänsel M, Buhl R, Rubin RA, Frey M, Glaab T

Preuzmi cijeli tekst

Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO® and OTEMTO® studies: a subgroup analysis by age od Ferguson GT, Karpel JP, Clerisme-Beaty E, Grönke L, Voß F, Buhl R

Preuzmi cijeli tekst

“Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD od Vogelmeier C, Worth H, Buhl R, Criée C, Lossi NS, Mailänder C, Kardos P

Preuzmi cijeli tekst

Dual bronchodilation vs triple therapy in the “real-life” COPD DACCORD study od Buhl R, Criée C, Kardos P, Vogelmeier CF, Kostikas K, Lossi NS, Worth H

Preuzmi cijeli tekst

A year in the life of German patients with COPD: the DACCORD observational study od Buhl R, Criée CP, Kardos P, Vogelmeier C, Lossi N, Mailänder C, Worth H

Preuzmi cijeli tekst

Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis od Buhl R, Wilke T, Picker N, Schmidt O, Hechtner M, Kondla A, Maywald U, Vogelmeier CF

Preuzmi cijeli tekst

A Non-Interventional Study of Tiotropium/Olodaterol versus Any Triple Combination Therapy for Chronic Obstructive Pulmonary Disease: The EVELUT® Study Protocol od Buhl R, Dreher M, Korn S, Taube C, Stock C, Zehendner CM, Kondla A, Vogelmeier CF

Preuzmi cijeli tekst

Costs and Clinical Consequences of Compliance with COPD GOLD Recommendations or National Guidelines Compared with Current Clinical Practice in Belgium, Germany, Sweden, and the Uni... od Sethi S, Wright A, Hartgers-Gubbels ES, Hechtner M, Clark B, Wright C, Langham S, Buhl R

Preuzmi cijeli tekst

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. od Pavord, I, Korn, S, Howarth, P, Bleecker, E, Buhl, R, Keene, O, Ortega, H, Chanez, P

Lung function and long-term safety of tiotropium/olodaterol in East Asian patients with chronic obstructive pulmonary disease od Bai C, Ichinose M, Lee SH, Lee KH, Jöns O, Bothner U, Zhao Y, Buhl R

Preuzmi cijeli tekst

Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study) od Korn S, Milger K, Skowasch D, Schulz C, Mohrlang C, Wernitz M, Paulsson T, Hennig M, Buhl R

Preuzmi cijeli tekst

Asthma Prevalence and Phenotyping in the General Population: The LEAD (Lung, hEart, sociAl, boDy) Study od Schiffers C, Wouters EF, Breyer-Kohansal R, Buhl R, Pohl W, Irvin CG, Breyer MK, Hartl S

Preuzmi cijeli tekst

Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months od Kayser MZ, Drick N, Milger K, Fuge J, Kneidinger N, Korn S, Buhl R, Behr J, Welte T, Suhling H

Preuzmi cijeli tekst

Absence of Adverse Effects of Tiotropium/Olodaterol Compared with the Monocomponents on Long-Term Heart Rate and Blood Pressure in Patients with Moderate-to-Very-Severe COPD od Andreas S, McGarvey L, Bothner U, Trampisch M, de la Hoz A, Fležar M, Buhl R, Alter P

Preuzmi cijeli tekst

Severe eosinophilic asthma: a roadmap to consensus. od Buhl, R, Humbert, M, Bjermer, L, Chanez, P, Heaney, L, Pavord, I, Quirce, S, Virchow, J, Holgate, S, Expert Group of the European Consensus Meeting for Severe Eosinophilic Asthma

Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? od Vanfleteren, L, Kocks, J, Stone, I, Breyer-Kohansal, R, Greulich, T, Lacedonia, D, Buhl, R, Fabbri, L, Pavord, I, Barnes, N, Wouters, E, Agusti, A